Anemia

Anemia, Chronic


 

 

Background: Chronic anemia has no precise definition. Anemia that persists for 6 months or more (eg, hereditary spherocytosis [HS]) is clearly chronic; however, an anemia that lasts only 2 months (eg, iron deficiency that is being treated) also should be considered a chronic anemia, and other explanations must be sought.

Pathophysiology: Chronic anemia can be primary or secondary.

Primary chronic anemias

These are the true chronic anemias, in which the anemia (defined as a hemoglobin level more than 2 standard deviations below the mean normal value for age) is part of the basic disease process. The basic disease process itself is hematological (eg, sickle cell disease, HS), and the degree of anemia is often acceptable.

Secondary chronic anemias

These are chronic anemias that may be the diagnostic clue to some chronic disease. Chronicity again is defined as anemia persisting beyond 2-6 months. These anemias are the consequence of a nonhematologic problem (eg, chronic osteomyelitis).

Frequency:

Mortality/Morbidity: Death from chronic anemia is extremely uncommon because of the adaptive ability of the cardiovascular system. Morbidity is also uncommon and usually is related to the primary disease process rather than the anemia per se. Shortness of breath and easy fatigability are unpredictable because some children tolerate extremely low hemoglobin concentrations in the range of 4-5 g/dL without any problem, whereas others are symptomatic at double that value. No evidence suggests that such low hemoglobin concentrations pose any systemic problem, but it can be very distressing to children and families. In situations of true red blood cell aplasia, the anemia eventually reaches a point where compensatory mechanisms are no longer adequate and congestive heart failure or syncope can result.

Race: Certain racial groups are much more likely than others to have inherited anemias. The hemoglobin S syndromes usually (though not invariably) are seen in populations of central African origin; the hemoglobin C syndromes are seen in populations of western African origin. The hemoglobin D syndromes usually are seen in populations of the northern Indian subcontinent, and hemoglobin E syndromes are seen in populations of southeastern Asia. The beta-thalassemias are seen in Mediterranean, Middle Eastern, and Southeast Asian populations. The alpha-thalassemias are seen in African and Asian populations. G-6-PD deficiency is more likely in individuals of Mediterranean or Southeast Asian origin.

Sex: Males are much more likely to have G-6-PD deficiency than females. The immune hemolytic anemias are more common in females because of the higher incidence of collagen vascular diseases. Chronic anemia may be hastened or exacerbated by menstrual blood loss.

Age: Early infancy is the usual time of onset of Diamond-Blackfan anemia. Later infancy is the time of onset of the homozygous or doubly heterozygous hemoglobinopathies. Chronic iron deficiency anemia first manifests in later infancy and the second year of life. The toddler years are the period of lead poisoning. The onset of menses once again leads to susceptibility to iron deficiency.

History: Chronic anemias are usually asymptomatic even at remarkably low levels of hemoglobin. Symptoms more often relate to the underlying cause (eg, lethargy if secondary to iron deficiency, shortness of breath if related to folic acid or vitamin B-12 deficiency, left upper quadrant pain if due to HS and splenomegaly, right upper quadrant pain if due to chronic hemolysis with subsequent cholelithiasis, constipation and cold intolerance if due to hypothyroidism). Although uncommon, there may be failure to thrive in infancy. Hemoglobin levels as low as 5-6 g are extremely well tolerated under stable circumstances and do not need transfusion. If the basic process is correctable, the anemia resolves without treatment.

Inquire carefully regarding any evidence of blood loss (eg, hemoptysis, hematochezia, melena, hematuria, menorrhagia). In endemic areas, a history of papulovesicular skin lesions on the feet may suggest a diagnosis of hookworms.

Age is always an important consideration. Iron deficiency is seen in older infants, toddlers, and menstruating girls. The deficiency can be surprisingly severe, but transfusion is indicated only in the rare circumstance of impending high-output cardiac failure.

The patient's sex must always be considered in hemolytic anemias. Severe G-6-PD deficiency may be seen as a chronic nonspherocytic anemia in males only.

Ethnicity is a factor in the hemoglobinopathies. The hemoglobin S syndromes usually (though not invariably) are seen in populations of central African origin; hemoglobin C syndromes are seen in populations of western African origin. The hemoglobin D syndromes usually are seen in northern Indian subcontinent populations, whereas hemoglobin E syndromes are seen in populations of southeastern Asia. The beta-thalassemias are seen in Mediterranean, Middle Eastern, and Southeast Asian populations. The alpha-thalassemias are seen in African and Asian populations. The thalassemias involving the beta chain are clinically silent in the first months of life and only become apparent after 6 or 9 months due to cessation of gamma chain production.

Dietary history is important with regard to the amount and source of milk that infants and toddlers ingest and to their risk of chronic iron deficiency. Food aversions (eg, to leafy vegetables) can cause predisposition to folic acid deficiency. Certain diets (eg, a vegan diet) could result in vitamin B-12 deficiency if continued over several years.

A careful review of past history is always crucial. Blood loss over an extended period results in iron deficiency. Chronic infection, such as chronic pyelonephritis, bacterial endocarditis, or osteomyelitis, results in the anemia of chronic disease. Any inflammatory process, such as chronic renal failure or a chronic collagen vascular disease, also results in the anemia of chronic disease. Episodic pain in the chest, abdomen, or extremities may reflect a diagnosis of sickle cell disease.

Drugs with oxidant properties trigger hemolysis due to G-6-PD deficiency, and this may become chronic if the drugs are continued for an extended period. Exposure to known marrow toxins, such as benzene or the antibiotic chloramphenicol, may result in aplastic anemia months after the actual exposure.

Neonatal history may provide useful information about a possibly overlooked congenital process that manifested after birth. Exaggerated jaundice as a newborn may be the clue for G-6-PD deficiency in males or for HS in either sex.

Family history is critical in any hereditary anemia. Anemia occurs in families with thalassemia syndromes. Gallstones, early cholecystectomy, and splenomegaly are common in families with HS.

Physical:

Causes:

DIFFERENTIALS

Anemia, Fanconi
Anemia, Megaloblastic
Evans Syndrome
Hemoglobin H Disease
Hereditary Elliptocytosis and Related Disorders
Hookworm Infection
Hypothyroidism
Myelodysplastic Syndrome
Myelofibrosis
Paroxysmal Cold Hemoglobinuria
Porphyria, Acute
Pyruvate Kinase Deficiency
Sickle Cell Anemia
Systemic Lupus Erythematosus
Thalassemia
Thalassemia Intermedia
Toxicity, Lead
Transient Erythroblastopenia of Childhood


Other Problems to be Considered:

AIDS
Congenital dyserythropoietic anemia
Diamond-Blackfan anemia
Glucose-6-phosphate dehydrogenase deficiency
Nutritional iron deficiency
Paroxysmal nocturnal hemoglobinuria
Pure red cell aplasia
Rheumatoid arthritis
Sideroblastic anemia
Unstable hemoglobinopathies

Imaging Studies:

Procedures:

Medical Care: Chronic anemia merits prompt if not immediate attention. Exclusion of impending high-output failure is the most important issue. High-output failure is the only reason that blood transfusion is necessary. Red blood cell transfusions must be given cautiously: rapid expansion of intravascular volume may cause congestive heart failure in a well-compensated patient. It may be necessary to give two or more small aliquots of RBCs with a few hours of re-equilibration between transfusions. Elective surgery usually can be performed without preoperative transfusion as long as blood is available.
For patients requiring long-term transfusional support, it is good to identify a limited number of dedicated blood donors. They are selected on the basis of detailed antigenic cross-matching with the patient, in hopes of avoiding the development of immune-mediated hemolysis. These patients will ultimately develop iron overload and are likely to require iron chelation therapy (see the article on thalassemia).

Surgical Care: Splenectomy usually is indicated with HS unless the degree of hemolysis is very minor. Ideally, delay splenectomy until patients are aged 8-9 years, by which time immunity to encapsulated bacteria is well established. This is also before hemolysis sufficient to result in bilirubin gallstones has typically occurred.

Consultations: Many of the chronic anemias can be diagnosed and managed by generalists. However, when subtle distinctions in morphology or the interpretation of laboratory data relative to the hemolytic anemias is important, a pediatric hematologist is usually necessary. Certainly, when bone marrow aspiration and biopsy are contemplated, the experience of a pediatric hematologist is essential.

Blood transfusion is discussed See the relevant article for details of treatment of each disease entity. In many circumstances, such as the congenital dyserythropoietic anemias, there is no specific treatment. Recombinant erythropoietin has been useful in the management of the anemias of chronic renal failure, rheumatoid arthritis, and AIDS: patients' hemoglobin levels and general feelings of well-being are much improved since recombinant erythropoietin has become commercially available.

Common sense should prevail in recognizing that, although the anemia may be quite profound, the patient is usually well. It is then prudent not to follow the hemoglobin level too closely and thereby create unnecessary apprehension in the family. When physiological adaptive mechanisms are in place, most children do well, and what is abnormal for others becomes normal for them. At this point, the art of medicine takes precedence over the science of medicine.

Further Inpatient Care:

Further Outpatient Care:

Complications:

Prognosis:

Patient Education:

Medical/Legal Pitfalls:

Bibliograghy

 

Home page, Drug information's ,Regional anesthesia ,Index for  diseases ,Index for  diseases, Perioperative medicine, Search engine, Accreditation, Learn Arabic Warfare, Anesthesia LINKS, Orthopedic LINKS, Midline

Constructed by Dr N.A. Nematallah Consultant in perioperative medicine and intensive therapy, Al Razi Orthopedic Hospital , State of Kuwait, email : razianesth@freeservers.com